Literature DB >> 22364520

Aging-associated alteration of telomere length and subtelomeric status in female patients with Parkinson's disease.

Toyoki Maeda1, Jing Zhi Guan, Masamichi Koyanagi, Yoshihiro Higuchi, Naoki Makino.   

Abstract

A telomere is a repetitive DNA structure at chromosomal ends that stabilizes the chromosome structure and prevents harmful end-to-end recombinations. The telomere length of somatic cells becomes shorter with aging because of the "end replication problem." This telomere shortening is accelerated by pathophysiological conditions including daily mental stress. Living with Parkinson's disease (PD) causes physical and mental stress; therefore, the authors hypothesized that the telomere length of somatic cells was shortened excessively in patients with PD. In order to detect PD-associated somatic telomeric alterations, the telomere length and subtelomeric methylation status of peripheral leukocytes of PD patients were assessed by Southern blotting, using methylation-sensitive and -insensitive isoschizomers. The results demonstrated that the peripheral leukocytes of Japanese female patients with PD bore fewer long telomeres and a proportional increase of hypomethylated subtelomeres in short telomeres in comparison with the healthy controls. This study indicates that with the neurodegeneration associated with PD, telomeric and subtelomeric structural alterations occur. These structural telomere alterations most likely occur secondary to the acceleration of aging-associated telomeric changes and the accelerated loss of cells bearing short telomeres.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22364520     DOI: 10.3109/01677063.2011.651665

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  18 in total

1.  Generating Late-Onset Human iPSC-Based Disease Models by Inducing Neuronal Age-Related Phenotypes through Telomerase Manipulation.

Authors:  Elsa Vera; Nazario Bosco; Lorenz Studer
Journal:  Cell Rep       Date:  2016-10-18       Impact factor: 9.423

2.  Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson's disease and Lewy body dementia.

Authors:  Muhammad Asghar; Amani Odeh; Ahmad Jouni Fattahi; Alexandra Edwards Henriksson; Aurelie Miglar; Shervin Khosousi; Per Svenningsson
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

3.  Telomere length in Parkinson's disease: A meta-analysis.

Authors:  Diego A Forero; Yeimy González-Giraldo; Catalina López-Quintero; Luis J Castro-Vega; George E Barreto; George Perry
Journal:  Exp Gerontol       Date:  2016-01-07       Impact factor: 4.032

Review 4.  Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins.

Authors:  George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-10-02       Impact factor: 5.590

Review 5.  Telomere shortening in neurological disorders: an abundance of unanswered questions.

Authors:  Erez Eitan; Emmette R Hutchison; Mark P Mattson
Journal:  Trends Neurosci       Date:  2014-03-31       Impact factor: 13.837

6.  Ageing affects subtelomeric DNA methylation in blood cells from a large European population enrolled in the MARK-AGE study.

Authors:  Maria Giulia Bacalini; Anna Reale; Marco Malavolta; Fabio Ciccarone; María Moreno-Villanueva; Martijn E T Dollé; Eugène Jansen; Tilman Grune; Efstathios S Gonos; Christiane Schön; Jürgen Bernhardt; Beatrix Grubeck-Loebenstein; Ewa Sikora; Olivier Toussaint; Florence Debacq-Chainiaux; Miriam Capri; Antti Hervonen; Mikko Hurme; P Eline Slagboom; Nicolle Breusing; Valentina Aversano; Stefano Tagliatesta; Claudio Franceschi; Maria A Blasco; Alexander Bürkle; Paola Caiafa; Michele Zampieri
Journal:  Geroscience       Date:  2021-04-19       Impact factor: 7.713

7.  Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism.

Authors:  Sofie Degerman; Magdalena Domellöf; Mattias Landfors; Jan Linder; Mathias Lundin; Susann Haraldsson; Eva Elgh; Göran Roos; Lars Forsgren
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

8.  Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients.

Authors:  Steve Horvath; Beate R Ritz
Journal:  Aging (Albany NY)       Date:  2015-12       Impact factor: 5.682

9.  Chromatin remodeling of human subtelomeres and TERRA promoters upon cellular senescence: commonalities and differences between chromosomes.

Authors:  Peter E Thijssen; Elmar W Tobi; Judit Balog; Suzanne G Schouten; Dennis Kremer; Fatiha El Bouazzaoui; Peter Henneman; Hein Putter; P Eline Slagboom; Bastiaan T Heijmans; Silvère M van der Maarel
Journal:  Epigenetics       Date:  2013-04-17       Impact factor: 4.528

10.  The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.

Authors:  Katarzyna Gaweda-Walerych; Cezary Zekanowski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.